Literature DB >> 30458534

Omalizumab Rescue Therapy for Refractory Status Asthmaticus.

Katrin Milger1, Ines Schroeder2, Jürgen Behr1, Tobias Meis3, Werner V Wulffen3, Nikolaus Kneidinger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30458534     DOI： 10.7326/L18-0359

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

Review 1.  Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.

Authors:  Nathan Schoettler; Mary E Strek
Journal:  Chest       Date:  2019-10-31       Impact factor: 9.410

2.  Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report.

Authors:  Johannes Anthon Kroes; Sander Wilhelm Zielhuis; Carina Bethlehem; Anneke Ten Brinke; Eric Nico Van Roon
Journal:  Eur J Hosp Pharm       Date:  2021-04-21

3.  Successful treatment of refractory status asthmaticus with omalizumab: a case report.

Authors:  Jan Benes; Roman Skulec; Dalibor Jilek; Ondrej Fibigr; Vladimir Cerny
Journal:  Allergy Asthma Clin Immunol       Date:  2021-12-09       Impact factor: 3.406

4.  Rescue therapy for refractory status asthmaticus with updosed omalizumab adjusted for IgE level, body weight and effect.

Authors:  Hortense Slevogt; Martin Brauer
Journal:  Respir Med Case Rep       Date:  2022-02-22

5.  Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use.

Authors:  Santi Nolasco; Raffaele Campisi; Rossella Intravaia; Morena Porto; Corrado Pelaia; Nunzio Crimi; Claudia Crimi
Journal:  F1000Res       Date:  2020-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.